Yahoo Web Search

Search results

  1. www.gene.comGenentech

    Genentech's legacy and future aspirations are built on the belief that the boundaries of science are meant to be broken and that we can solve some of the hardest biomedical challenges plaguing humankind. Learn More. Quick Links. Advancing Inclusive Research. Patient Financial Support.

    • Visit Us

      All of Genentech's U.S. sites are united by our goal of...

    • Genentech: About Us

      Considered the founder of the industry, Genentech, now a...

    • Call Us

      Genentech Patient Foundation. The Genentech Patient...

    • Medical Professionals

      Genentech Access Solutions offers your patients coverage...

  2. Genentech is a biotechnology company that discovers and develops medicines for serious and life-threatening diseases. Learn about its history, mission, values, and podcast series on human biology.

  3. en.wikipedia.org › wiki › GenentechGenentech - Wikipedia

    Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.

  4. For more than 45 years, we've been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions. We are headquartered in South San Francisco, California.

  5. Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

  6. Genentech is committed to defeating cancer. Building upon our legacy as pioneers in oncology, we're boldly innovating beyond the science and envision a better future for every cancer patient, caregiver, and provider. We can't do it alone.

  7. 1 day ago · A refillable implant for a blinding eye disease, pulled from the market two years ago by Genentech Inc., will be reintroduced within weeks of the updated device's approval by regulators.